🔎 Trials Near Me

Home › Kanser sa Baga › Alaska

Pag-aaral pangklinika para sa Kanser sa Baga sa Alaska

9 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa Alaska.

Mga Lungsod sa Alaska

Opisyal na teksto ng pag-aaral (English)

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • Fairbanks Cancer Care Physicians, PC, Fairbanks
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06758401

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Katmai Oncology Group, Anchorage
  • Fairbanks Memorial Hospital, Fairbanks
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04267848

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

  • Alaska Oncology and Hematology, Anchorage
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07777822

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Anchorage Associates in Radiation Medicine, Anchorage
  • Alaska Breast Care and Surgery LLC, Anchorage
  • Alaska Oncology and Hematology LLC, Anchorage
  • at 3 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

  • Katmai Oncology Group, Anchorage
  • Fairbanks Memorial Hospital, Fairbanks
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT04181060

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • Alaska Oncology and Hematology, LLC, Anchorage
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT06712316

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

  • Alaska Oncology and Hematology, Anchorage
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07128199

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Katmai Oncology Group, Anchorage
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.